Bridging Medical Research and Health
The Kolling Research Strategy 2021-2025 is strengthening our ability to achieve ground-breaking research, while delivering new opportunities and greater assistance to our teams.
The research strategy is focusing on areas of strength, drawing upon the expertise and resources of the University of Sydney and the Northern Sydney Local Health District, and positioning the institute as a hub of translational research excellence.
Researchers are supported to translate scientific discoveries into positive outcomes for clinical practice and community health.
Research Strategy Brochure
Click here to see our full research strategy or click the button below to download it.
Priority Research Areas
Musculoskeletal – Neuroscience and Pain – Cardiovascular and Renal Research
These areas of research investigate some of the biggest health challenges of our time. Collectively, they cost the community billions of dollars a year in health, personal and economic costs.
Kolling Institute researchers are well respected, with unique skills and knowledge, strong industry links and a track record of success.
They are well placed to strengthen their international, government and industry collaborations, and increase the impact of their research.
Research Enablers
A key component of the Kolling Institute’s Research Strategy is the provision of four Kolling research enablers. These will provide research teams with new opportunities, modern platforms and infrastructure, increasing competitiveness, career development and core facility support.
Clinical Trials and Translation
Data and Informatics
Research Infrastructure & Support Services
Recruitment and Retention
Events, News and Seminars
Groundbreaking work in geriatric pharmacology
Posted on: 29 January, 2025
For the past 20 years, Professor Sarah Hilmer has dedicated her career to optimising medicine use fo..... Read more
Category: Neuroscience and Pain Research, New Treatment, Research Excellence
Top pain specialist and researcher receives Australia Day gong
Posted on: 28 January, 2025
Internationally respected clinical academic Professor Paul Glare has been named a Member of the Ord..... Read more
Category: Awards, Research Excellence
Clinical Trials Champion
Posted on: 20 January, 2025
As a clinical trials program lead at the Kolling Institute, Dr Karen Bracken has long been driven to..... Read more
Category: Musculoskeletal Research, New Treatment, Research Excellence